Emerald Acquisition’s Bristol-Myers Squibb BMY Stock Holding History

Emerald Acquisition’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$155M	Buy	2,878,054 +146,987	+5%	+$9.44M	0.3%	62
2016 Q2	$201M	Buy	+2,731,067	New	+$193M	0.35%	46

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Emerald Acquisition's BMY Position: Q3 2016 in Review

Emerald Acquisition increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q3 2016, buying an estimated $9.44M and bringing the position to 2,878,054 shares worth $155M. The position accounts for 0.3% of the portfolio, ranked #62.

Emerald Acquisition first reported a position in BMY in Q2 2016 and has held it in 2 quarters since. The position peaked at $201M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Emerald Acquisition held 2,878,054 shares of Bristol-Myers Squibb worth $155M as of Q3 2016.
Emerald Acquisition bought 146,987 Bristol-Myers Squibb shares in Q3 2016, an estimated $9.44M.
Bristol-Myers Squibb made up 0.3% of Emerald Acquisition's portfolio in Q3 2016, its #62 holding.
Emerald Acquisition first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 2 quarters since.
Emerald Acquisition's Bristol-Myers Squibb position peaked at $201M in Q2 2016.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.